Cellular rejuvenation therapy safely reverses signs of aging in mice.
Credit: Salk Institute
Salk researchers treated mice with anti-aging regimen beginning in middle age and found no increase in cancer or other health problems later on
Age may be just a number, but it’s a number that often carries unwanted side effects, from brittle bones and weaker muscles to increased risks of cardiovascular disease and cancer. Now, scientists at the Salk Institute, in collaboration with Genentech, a member of the Roche group, have shown that they can safely and effectively reverse the aging process in middle-aged and elderly mice by partially resetting their cells to more youthful states.
“We are elated that we can use this approach across the life span to slow down aging in normal animals. The technique is both safe and effective in mice,” says co-corresponding author Juan Carlos Izpisua Belmonte, professor in Salk’s Gene Expression Laboratory and holder of the Roger Guillemin Chair. “In addition to tackling age-related diseases, this approach may provide the biomedical community with a new tool to restore tissue and organismal health by improving cell function and resilience in different disease situations, such as neurodegenerative diseases.”
As organisms age, it is not just their outward appearances and health that change; every cell in their bodies carries a molecular clock that records the passage of time. Cells isolated from older people or animals have different patterns of chemicals along their DNA—called epigenetic markers—compared to younger people or animals. Scientists know that adding a mixture of four reprogramming molecules—Oct4, Sox2, Klf4 and cMyc, also known as “Yamanaka factors”—to cells can reset these epigenetic marks to their original patterns. This approach is how researchers can dial back adult cells, developmentally speaking, into stem cells.
In 2016, Izpisua Belmonte’s lab reported for the first time that they could use the Yamanaka factors to counter the signs of aging and increase life span in mice with a premature aging disease. More recently, the team found that, even in young mice, the Yamanaka factors can accelerate muscle regeneration. Following these initial observations, other scientists have used the same approach to improve the function of other tissues like the heart, brain and optic nerve, which is involved in vision.
In the new study, Izpisua Belmonte and his colleagues tested variations of the cellular rejuvenation approach in healthy animals as they aged. One group of mice received regular doses of the Yamanaka factors from the time they were 15 months old until 22 months, approximately equivalent to age 50 through 70 in humans. Another group was treated from 12 through 22 months, approximately age 35 to 70 in humans. And a third group was treated for just one month at age 25 months, similar to age 80 in humans.
“What we really wanted to establish was that using this approach for a longer time span is safe,” says Pradeep Reddy, a Salk staff scientist and co-first author of the new paper. “Indeed, we did not see any negative effects on the health, behavior or body weight of these animals.”
Compared to control animals, there were no blood cell alterations or neurological changes in the mice that had received the Yamanaka factors. Moreover, the team found no cancers in any of the groups of animals.
When the researchers looked at normal signs of aging in the animals that had undergone the treatment, they found that the mice, in many ways, resembled younger animals. In both the kidneys and skin, the epigenetics of treated animals more closely resembled epigenetic patterns seen in younger animals. When injured, the skin cells of treated animals had a greater ability to proliferate and were less likely to form permanent scars—older animals usually show less skin cell proliferation and more scarring. Moreover, metabolic molecules in the blood of treated animals did not show normal age-related changes.
This youthfulness was observed in the animals treated for seven or 10 months with the Yamanaka factors, but not the animals treated for just one month. What’s more, when the treated animals were analyzed midway through their treatment, the effects were not yet as evident. This suggests that the treatment is not simply pausing aging, but actively turning it backwards—although more research is needed to differentiate between the two.
The team is now planning future research to analyze how specific molecules and genes are changed by long-term treatment with the Yamanaka factors. They are also developing new ways of delivering the factors.
“At the end of the day, we want to bring resilience and function back to older cells so that they are more resistant to stress, injury and disease,” says Reddy. “This study shows that, at least in mice, there’s a path forward to achieving that.”
Original Article: Cellular rejuvenation therapy safely reverses signs of aging in mice
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Could a drug for high blood pressure help slow aging?
A new study suggests that rilmenidine, a drug that treats hypertension, could also have anti-aging benefits. The researchers tested the drug's potential in a roundworm model.
- Startup founder's extreme reverse-aging routine • Horizon-Amgen deal faces resistance • Abbott device OK'd for diabetic nerve pain
Bryan Johnson, who made his fortune in his 30s when he sold his Chicago-based startup Braintree to eBay in 2013, is now attempting to bioengineer himself back into the body of an 18-year-old. In a new ...
- Wealthy Entrepreneur Reversed His Biological Age with a $2 Million Treatment Program
Led by regenerative medicine physician Oliver Zolman, 29, the team aims to reverse the aging process in every organ. Flu, COVID and RSV Cases All Trending Downward — for the First Time in Months ...
- Tech entrepreneur, 45, spends $2m a year on reverse ageing to achieve body of an 18 year old: ‘Horrifying’
Since then, the 45-year-old has turned his attention inward and is now focused on reversing the ageing process. The treatment plan, which is overseen by Oliver Zolman, a 29-year-old regenerative ...
- Reverse Aging Is Real, Here's How One Man Did It
In reality, it is more than a storybook ending and would mean if humans could control the sands of time and achieve reverse aging, then we could drastically lengthen the life expectancy of our race, ...
Go deeper with Google Headlines on:
[google_news title=”” keyword=”reversing aging” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
- 6 Factors That Affect Our Spine Health
However, there are several factors that can affect the health of our spine, leading to pain, discomfort, and even disability. One of the most significant factors that can affect our spine health ...
- New research furthers case for exercise promoting youthfulness
The Yamanaka factors are four protein transcription factors (identified as Oct3/4, Sox2, Klf4 and c-Myc, often abbreviated to OKSM) that can revert highly specified cells (such as a skin cell ...
- Why you shouldn’t get too excited at claims scientists have reversed ageing… yet
Two new studies in mice make big claims about anti-ageing treatments - but there are many unanswered questions ...
- Key Alzheimer's risk factors affect men more than women, study shows
Scientists at the University of Alberta have discovered that important risk factors in Alzheimer's disease affect males and females very differently. "Two types of risk for Alzheimer's disease ...
- Exercise promotes a molecular profile in muscle: Research
The Yamanaka factors are four protein transcription factors (identified as Oct3/4, Sox2, Klf4 and c-Myc, often abbreviated to OKSM) that can revert highly specified cells (such as a skin cell) back to ...
Go deeper with Google Headlines on:
[google_news title=”” keyword=”Yamanaka factors” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]